The purpose of these guidelines is to assist physicians in recommending, performing, interpreting
and reporting the results of FDG PET/CT for oncological imaging of adult patients. PET …

Tumours respond differently to immunotherapies compared with chemotherapeutic drugs,
raising questions about the assessment of changes in tumour burden—a mainstay of …

The aim of this guideline is to provide a minimum standard for the acquisition and interpretation
of PET and PET/CT scans with [18F]-fluorodeoxyglucose (FDG). This guideline will …

Purpose Recent advances in imaging, use of prognostic indices, and molecular profiling
techniques have the potential to improve disease characterization and outcomes in lymphoma. …

… The Imaging subcommittee’s charge was to develop guidelines for performing and
interpreting FDG-PET for treatment assessment in lymphoma, to ensure the reliability of the …

The Response Evaluation Criteria in Solid Tumours (RECIST) were developed and published
in 2000, based on the original World Health Organisation guidelines first published in …

Imaging biomarkers (IBs) are integral to the routine management of patients with cancer. IBs
used daily in oncology include clinical TNM stage, objective response and left ventricular …

Background Up to 50% of curative surgery for suspected non-small-cell lung cancer is
unsuccessful. Accuracy of positron emission tomography (PET) with 18-fluorodeoxyglucose ( 18 …

Semiquantitative standard uptake values (SUVs) are used for tumor diagnosis and response
monitoring. However, the accuracy of the SUV and the accuracy of relative change during …

PURPOSE: Variable uptake of the glucose analog 18 fluorodeoxyglucose (FDG) has been
noticed in positron emission tomography (PET) studies of breast cancer patients, with low …